150 related articles for article (PubMed ID: 24303755)
21. Inhibition of Drp1 attenuates mitochondrial damage and myocardial injury in Coxsackievirus B3 induced myocarditis.
Lin L; Zhang M; Yan R; Shan H; Diao J; Wei J
Biochem Biophys Res Commun; 2017 Mar; 484(3):550-556. PubMed ID: 28131843
[TBL] [Abstract][Full Text] [Related]
22. Change in the cells that express connective tissue growth factor in acute Coxsackievirus-induced myocardial fibrosis in mouse.
Yun SH; Shin JO; Lim BK; Kim KL; Gil CO; Kim DK; Jeon ES
Virus Res; 2007 Jun; 126(1-2):62-8. PubMed ID: 17350707
[TBL] [Abstract][Full Text] [Related]
23. [Roles of cardiac mast cells and Toll-like receptor 4 in viral myocarditis among mice].
Li H; Huang LF; Wen C; Yang ZC; Chen CY
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Oct; 15(10):896-902. PubMed ID: 24131845
[TBL] [Abstract][Full Text] [Related]
24. [Role of interleukin 17 in viral myocarditis and dilated cardiomyopathy].
Lin S; Huang YL; Wu WF; Li Y; Tang SD
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct; 29(10):1994-9. PubMed ID: 19861249
[TBL] [Abstract][Full Text] [Related]
25. Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis.
Li K; Xu W; Guo Q; Jiang Z; Wang P; Yue Y; Xiong S
Circ Res; 2009 Aug; 105(4):353-64. PubMed ID: 19608981
[TBL] [Abstract][Full Text] [Related]
26. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
Szalay G; Sauter M; Haberland M; Zuegel U; Steinmeyer A; Kandolf R; Klingel K
Circ Res; 2009 Apr; 104(7):851-9. PubMed ID: 19246678
[TBL] [Abstract][Full Text] [Related]
27. MiR-1/133 attenuates cardiomyocyte apoptosis and electrical remodeling in mice with viral myocarditis.
Li W; Liu M; Zhao C; Chen C; Kong Q; Cai Z; Li D
Cardiol J; 2020; 27(3):285-294. PubMed ID: 30994182
[TBL] [Abstract][Full Text] [Related]
28. The heart-protective mechanism of Qishaowuwei formula on murine viral myocarditis induced by CVB3.
Fengqin L; Yulin W; Xiaoxin Z; Youpeng J; Yan C; Qing-qing W; Hong C; Jia S; Lei H
J Ethnopharmacol; 2010 Feb; 127(2):221-8. PubMed ID: 19932162
[TBL] [Abstract][Full Text] [Related]
29. [Expression of coxsackie-adenovirus receptor in hearts of mice with experimental viral myocarditis and its regulatory mechanism].
Yu XH; Zhang P; Zhang XG
Zhonghua Er Ke Za Zhi; 2006 Feb; 44(2):137-8. PubMed ID: 16624033
[No Abstract] [Full Text] [Related]
30. [Effect of IL-17A on levels of antiheart autoantibodies in mice with viral myocarditis].
Lai W; Wu W; Pan X; Kong Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):601-3, 607. PubMed ID: 24909282
[TBL] [Abstract][Full Text] [Related]
31. Necroptosis may be a novel mechanism for cardiomyocyte death in acute myocarditis.
Zhou F; Jiang X; Teng L; Yang J; Ding J; He C
Mol Cell Biochem; 2018 May; 442(1-2):11-18. PubMed ID: 28887702
[TBL] [Abstract][Full Text] [Related]
32. [Alteration of Th17 cells in mice with coxsackie virus induced myocarditis].
YANG F; LIN S; HUANG YL; WU WF
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep; 38(9):790-3. PubMed ID: 21092645
[TBL] [Abstract][Full Text] [Related]
33. Cardioprotection of H2S by downregulating iNOS and upregulating HO-1 expression in mice with CVB3-induced myocarditis.
Hua W; Chen Q; Gong F; Xie C; Zhou S; Gao L
Life Sci; 2013 Dec; 93(24):949-54. PubMed ID: 24140888
[TBL] [Abstract][Full Text] [Related]
34. Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice.
Glück B; Schmidtke M; Merkle I; Stelzner A; Gemsa D
J Mol Cell Cardiol; 2001 Sep; 33(9):1615-26. PubMed ID: 11549341
[TBL] [Abstract][Full Text] [Related]
35. Roles of programmed death-1 (PD-1)/PD-1 ligands pathway in the development of murine acute myocarditis caused by coxsackievirus B3.
Seko Y; Yagita H; Okumura K; Azuma M; Nagai R
Cardiovasc Res; 2007 Jul; 75(1):158-67. PubMed ID: 17434153
[TBL] [Abstract][Full Text] [Related]
36. Atorvastatin attenuates Coxsackie virus B3m-induced viral myocarditis in mice.
Guan J; Sun X; Liang Y; Dong W; Zhang L; Zhu J; Wang G
J Cardiovasc Pharmacol; 2010 Nov; 56(5):540-7. PubMed ID: 20729751
[TBL] [Abstract][Full Text] [Related]
37. Temporal changes in stem cells in the circulation and myocardium of mice with Coxsackie virus B3-induced myocarditis.
Zhao L; Li S; Ge J; Sun A; Zou Y; Zhang S
Microvasc Res; 2008 Apr; 75(3):358-66. PubMed ID: 18206181
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of miR-29b suppresses MAPK signaling pathway through targeting SPRY1 in atherosclerosis.
Lu Z; Wang F; Yu P; Wang X; Wang Y; Tang ST; Zhu HQ
Vascul Pharmacol; 2018 Mar; 102():29-36. PubMed ID: 29398368
[TBL] [Abstract][Full Text] [Related]
39. Initial weight and virus dose: two factors affecting the onset of acute coxsackievirus B3 myocarditis in C57BL/6 mouse--a histopathology-based study.
Li M; Wang X; Xie Y; Xie Y; Zhang X; Zou Y; Ge J; Chen R
Cardiovasc Pathol; 2013; 22(1):96-101. PubMed ID: 22784985
[TBL] [Abstract][Full Text] [Related]
40. Melittin ameliorates CVB3-induced myocarditis via activation of the HDAC2-mediated GSK-3β/Nrf2/ARE signaling pathway.
Wang T; Zhang J; Xiao A; Liu W; Shang Y; An J
Biochem Biophys Res Commun; 2016 Nov; 480(1):126-131. PubMed ID: 27693786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
